All Videos Channels

Great-Martyrs Theodore Recruit and General

3 Followers

Sts. Theodore’s Mission statement: "Enlightening those in darkness" Our Lord and Savior Jesus Christ taught us that we are called to be a light to the world. Also by walking in the light of Christ we naturally reaffirm the true Orthodox philotimo (meaning the Holy Spirit guiding a community in its beliefs and aspirations through the contemplation of the Holy Trinity) amongst our brothers and sisters in the Orthodox Church. LINKS: Sts. Theodore ststheodore.org Eastern American Diocese eadiocese.org Holy Trinity Monastery jordanville.org Orthodox Life orthodoxlife.org Orthodox Wisdom youtube.com/@OrthodoxWisdom

Hyperdrive Recruiting

0 Followers

Home of the Imperial Security Bureau Podcast where you can find interviews with leaders in Cybersecurity & AI. We dive into each guest's career path/expertise, tactics/strategies for success, new tools & technologies, recent news/trends in Cybersecurity & AI. We routinely share advice for job seekers & how to hire/retain top talent. Hyperdrive Recruiting is a boutique recruiting agency based in Raleigh, NC specializing in Cybersecurity, AI, Software Engineering, Data, UX/Product Design, Digital Marketing, SaaS Sales, and Leadership roles for tech companies nationwide. The host of the show, Blake Williams, is a seasoned Technical Recruiter and shares insights about the current job market and recruiting trends. Guest are encouraged to ask anything they want to know about recruiting. You may notice the podcast and recruiting agency have a Star Wars theme so we may chat sci-fi on occasion too. May the force be with you. Find Me Here: https://linktr.ee/blakewilliams4u

Canadian phase 2 clinical trial, recruiting patients.

0 Followers

C Difficile is a gram positive spore forming bacteria, which can cause severe gut infection. It infects and kills 500,000 and 30,000 North Americans respectively every year. Standard of care treatment is Vancomycin antibiotic, which is effective in 60 to 70% of cases. When unsuccessful, the infection can recur and likeliness of recurrence increases after every treatment failure. Its treatment is considered an unmet medical need by the FDA and as such new treatments showing positive potential are typically fast tracked. ImmuniMed Inc, a Canadian clinical stage Biopharmaceutical company is presently in phase 2 clinical trial of its oral dose antibody treatment and recruiting patients. If you are a Canadian resident, over the age of 18 and have tested positive for c Difficile, please contact us to participate in this trial. John Hare John@immunimed.com 204-955-8495